NovoCure Limited NVCR
| Analyst |
Entreprise |
Price during analysis |
Target price |
Potential gain |
Publication date |
| Larry Biegelsen |
Wells Fargo |
12.54 $ |
14.5 $ |
1.96 % |
24/07/2025 |
| Vijay Kumar |
Evercore ISI |
26.425 $ |
30 $ |
3.58 % |
02/12/2024 |
| Emily Bodnar |
H.C. Wainwright |
17.78 $ |
30 $ |
12.22 % |
16/10/2024 |
| Emily Bodnar |
H.C. Wainwright |
18.255 $ |
24 $ |
5.75 % |
26/07/2024 |
| Emily Bodnar |
H.C. Wainwright |
14.19 $ |
22 $ |
7.81 % |
03/05/2024 |
| Vijay Kumar |
Evercore ISI |
14.78 $ |
14.5 $ |
-0.28 % |
02/05/2024 |
| Jason Bednar |
Piper Sandler |
14.88 $ |
28 $ |
13.12 % |
10/04/2024 |
| Larry Biegelsen |
Wells Fargo |
14.39 $ |
42 $ |
27.61 % |
03/04/2024 |
| Emily Bodnar |
H.C. Wainwright |
107.44 $ |
140 $ |
32.56 % |
05/01/2023 |
| Emily Bodnar |
H.C. Wainwright |
65.24 $ |
115 $ |
49.76 % |
16/05/2022 |
| Jason Wittes |
Loop Capital Markets |
75.3 $ |
200 $ |
124.70 % |
08/02/2022 |